nodes	percent_of_prediction	percent_of_DWPC	metapath
Saquinavir—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.631	1	CbGbCtD
Saquinavir—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.00887	0.026	CcSEcCtD
Saquinavir—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.00794	0.0233	CcSEcCtD
Saquinavir—Cardiac murmur—Riluzole—amyotrophic lateral sclerosis	0.00794	0.0233	CcSEcCtD
Saquinavir—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.00648	0.019	CcSEcCtD
Saquinavir—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.00579	0.017	CcSEcCtD
Saquinavir—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.00579	0.017	CcSEcCtD
Saquinavir—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00502	0.0147	CcSEcCtD
Saquinavir—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00495	0.0145	CcSEcCtD
Saquinavir—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00488	0.0143	CcSEcCtD
Saquinavir—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0045	0.0132	CcSEcCtD
Saquinavir—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00445	0.0131	CcSEcCtD
Saquinavir—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0127	CcSEcCtD
Saquinavir—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00414	0.0122	CcSEcCtD
Saquinavir—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0119	CcSEcCtD
Saquinavir—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.004	0.0118	CcSEcCtD
Saquinavir—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0115	CcSEcCtD
Saquinavir—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0111	CcSEcCtD
Saquinavir—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00376	0.011	CcSEcCtD
Saquinavir—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00376	0.011	CcSEcCtD
Saquinavir—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0108	CcSEcCtD
Saquinavir—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00361	0.0106	CcSEcCtD
Saquinavir—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00361	0.0106	CcSEcCtD
Saquinavir—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0105	CcSEcCtD
Saquinavir—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0105	CcSEcCtD
Saquinavir—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0104	CcSEcCtD
Saquinavir—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0102	CcSEcCtD
Saquinavir—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0102	CcSEcCtD
Saquinavir—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00342	0.01	CcSEcCtD
Saquinavir—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00977	CcSEcCtD
Saquinavir—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00929	CcSEcCtD
Saquinavir—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00914	CcSEcCtD
Saquinavir—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00899	CcSEcCtD
Saquinavir—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00879	CcSEcCtD
Saquinavir—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00872	CcSEcCtD
Saquinavir—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00806	CcSEcCtD
Saquinavir—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00795	CcSEcCtD
Saquinavir—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00785	CcSEcCtD
Saquinavir—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00779	CcSEcCtD
Saquinavir—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00764	CcSEcCtD
Saquinavir—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00764	CcSEcCtD
Saquinavir—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00764	CcSEcCtD
Saquinavir—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00764	CcSEcCtD
Saquinavir—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00736	CcSEcCtD
Saquinavir—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00723	CcSEcCtD
Saquinavir—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00715	CcSEcCtD
Saquinavir—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00706	CcSEcCtD
Saquinavir—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0069	CcSEcCtD
Saquinavir—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00664	CcSEcCtD
Saquinavir—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00654	CcSEcCtD
Saquinavir—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00621	CcSEcCtD
Saquinavir—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00615	CcSEcCtD
Saquinavir—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00615	CcSEcCtD
Saquinavir—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00603	CcSEcCtD
Saquinavir—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00603	CcSEcCtD
Saquinavir—Deafness—Riluzole—amyotrophic lateral sclerosis	0.002	0.00587	CcSEcCtD
Saquinavir—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00584	CcSEcCtD
Saquinavir—Injury—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00571	CcSEcCtD
Saquinavir—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00566	CcSEcCtD
Saquinavir—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00559	CcSEcCtD
Saquinavir—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00559	CcSEcCtD
Saquinavir—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00551	CcSEcCtD
Saquinavir—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0054	CcSEcCtD
Saquinavir—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00527	CcSEcCtD
Saquinavir—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00525	CcSEcCtD
Saquinavir—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00525	CcSEcCtD
Saquinavir—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00521	CcSEcCtD
Saquinavir—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00513	CcSEcCtD
Saquinavir—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00493	CcSEcCtD
Saquinavir—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00488	CcSEcCtD
Saquinavir—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00485	CcSEcCtD
Saquinavir—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00478	CcSEcCtD
Saquinavir—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00473	CcSEcCtD
Saquinavir—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00464	CcSEcCtD
Saquinavir—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00463	CcSEcCtD
Saquinavir—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00463	CcSEcCtD
Saquinavir—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00457	CcSEcCtD
Saquinavir—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00454	CcSEcCtD
Saquinavir—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00454	CcSEcCtD
Saquinavir—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00454	CcSEcCtD
Saquinavir—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00445	CcSEcCtD
Saquinavir—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00436	CcSEcCtD
Saquinavir—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00435	CcSEcCtD
Saquinavir—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00431	CcSEcCtD
Saquinavir—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00424	CcSEcCtD
Saquinavir—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00418	CcSEcCtD
Saquinavir—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00414	CcSEcCtD
Saquinavir—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00413	CcSEcCtD
Saquinavir—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0041	CcSEcCtD
Saquinavir—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00407	CcSEcCtD
Saquinavir—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00404	CcSEcCtD
Saquinavir—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00404	CcSEcCtD
Saquinavir—Depression—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00403	CcSEcCtD
Saquinavir—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00396	CcSEcCtD
Saquinavir—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00394	CcSEcCtD
Saquinavir—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00394	CcSEcCtD
Saquinavir—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00393	CcSEcCtD
Saquinavir—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00383	CcSEcCtD
Saquinavir—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00381	CcSEcCtD
Saquinavir—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00379	CcSEcCtD
Saquinavir—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00365	CcSEcCtD
Saquinavir—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00364	CcSEcCtD
Saquinavir—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00363	CcSEcCtD
Saquinavir—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00363	CcSEcCtD
Saquinavir—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00361	CcSEcCtD
Saquinavir—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00361	CcSEcCtD
Saquinavir—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0036	CcSEcCtD
Saquinavir—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00359	CcSEcCtD
Saquinavir—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00357	CcSEcCtD
Saquinavir—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00356	CcSEcCtD
Saquinavir—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00343	CcSEcCtD
Saquinavir—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00339	CcSEcCtD
Saquinavir—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00337	CcSEcCtD
Saquinavir—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00329	CcSEcCtD
Saquinavir—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00328	CcSEcCtD
Saquinavir—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00327	CcSEcCtD
Saquinavir—Chills—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00326	CcSEcCtD
Saquinavir—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00321	CcSEcCtD
Saquinavir—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00318	CcSEcCtD
Saquinavir—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00316	CcSEcCtD
Saquinavir—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00311	CcSEcCtD
Saquinavir—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0031	CcSEcCtD
Saquinavir—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00306	CcSEcCtD
Saquinavir—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00304	CcSEcCtD
Saquinavir—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00296	CcSEcCtD
Saquinavir—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000999	0.00293	CcSEcCtD
Saquinavir—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000995	0.00292	CcSEcCtD
Saquinavir—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000989	0.0029	CcSEcCtD
Saquinavir—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000971	0.00285	CcSEcCtD
Saquinavir—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000967	0.00284	CcSEcCtD
Saquinavir—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000966	0.00283	CcSEcCtD
Saquinavir—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000964	0.00283	CcSEcCtD
Saquinavir—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000946	0.00278	CcSEcCtD
Saquinavir—Cough—Riluzole—amyotrophic lateral sclerosis	0.00094	0.00276	CcSEcCtD
Saquinavir—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00274	CcSEcCtD
Saquinavir—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00093	0.00273	CcSEcCtD
Saquinavir—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00269	CcSEcCtD
Saquinavir—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00269	CcSEcCtD
Saquinavir—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00269	CcSEcCtD
Saquinavir—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000913	0.00268	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00091	0.00267	CcSEcCtD
Saquinavir—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000906	0.00266	CcSEcCtD
Saquinavir—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000896	0.00263	CcSEcCtD
Saquinavir—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000886	0.0026	CcSEcCtD
Saquinavir—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000879	0.00258	CcSEcCtD
Saquinavir—Infection—Riluzole—amyotrophic lateral sclerosis	0.000873	0.00256	CcSEcCtD
Saquinavir—Shock—Riluzole—amyotrophic lateral sclerosis	0.000865	0.00254	CcSEcCtD
Saquinavir—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000862	0.00253	CcSEcCtD
Saquinavir—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00086	0.00253	CcSEcCtD
Saquinavir—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000854	0.00251	CcSEcCtD
Saquinavir—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000849	0.00249	CcSEcCtD
Saquinavir—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000838	0.00246	CcSEcCtD
Saquinavir—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000821	0.00241	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000801	0.00235	CcSEcCtD
Saquinavir—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000795	0.00233	CcSEcCtD
Saquinavir—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000789	0.00232	CcSEcCtD
Saquinavir—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000783	0.0023	CcSEcCtD
Saquinavir—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000781	0.00229	CcSEcCtD
Saquinavir—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00227	CcSEcCtD
Saquinavir—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000764	0.00224	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000759	0.00223	CcSEcCtD
Saquinavir—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000758	0.00222	CcSEcCtD
Saquinavir—Pain—Riluzole—amyotrophic lateral sclerosis	0.000751	0.00221	CcSEcCtD
Saquinavir—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000751	0.00221	CcSEcCtD
Saquinavir—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000724	0.00213	CcSEcCtD
Saquinavir—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000719	0.00211	CcSEcCtD
Saquinavir—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000698	0.00205	CcSEcCtD
Saquinavir—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000695	0.00204	CcSEcCtD
Saquinavir—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000695	0.00204	CcSEcCtD
Saquinavir—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000647	0.0019	CcSEcCtD
Saquinavir—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00063	0.00185	CcSEcCtD
Saquinavir—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000622	0.00182	CcSEcCtD
Saquinavir—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000601	0.00176	CcSEcCtD
Saquinavir—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000581	0.00171	CcSEcCtD
Saquinavir—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000559	0.00164	CcSEcCtD
Saquinavir—Rash—Riluzole—amyotrophic lateral sclerosis	0.000554	0.00163	CcSEcCtD
Saquinavir—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000554	0.00162	CcSEcCtD
Saquinavir—Headache—Riluzole—amyotrophic lateral sclerosis	0.00055	0.00162	CcSEcCtD
Saquinavir—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000522	0.00153	CcSEcCtD
Saquinavir—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.28e-05	0.00149	CbGpPWpGaD
Saquinavir—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	4.17e-05	0.00145	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	4.17e-05	0.00145	CbGpPWpGaD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.15e-05	0.00145	CbGpPWpGaD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.15e-05	0.00145	CbGpPWpGaD
Saquinavir—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.11e-05	0.00143	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	4.06e-05	0.00141	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	4.06e-05	0.00141	CbGpPWpGaD
Saquinavir—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.05e-05	0.00141	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.03e-05	0.0014	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	4.02e-05	0.0014	CbGpPWpGaD
Saquinavir—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.01e-05	0.0014	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.98e-05	0.00139	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	3.96e-05	0.00138	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.87e-05	0.00135	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.85e-05	0.00134	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	3.77e-05	0.00131	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	3.77e-05	0.00131	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.76e-05	0.00131	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.74e-05	0.0013	CbGpPWpGaD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.7e-05	0.00129	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	3.67e-05	0.00128	CbGpPWpGaD
Saquinavir—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.67e-05	0.00128	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	3.65e-05	0.00127	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	3.64e-05	0.00127	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	3.64e-05	0.00127	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	3.64e-05	0.00127	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.63e-05	0.00127	CbGpPWpGaD
Saquinavir—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	3.62e-05	0.00126	CbGpPWpGaD
Saquinavir—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.62e-05	0.00126	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.51e-05	0.00122	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.46e-05	0.00121	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	3.43e-05	0.00119	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.38e-05	0.00118	CbGpPWpGaD
Saquinavir—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.37e-05	0.00118	CbGpPWpGaD
Saquinavir—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	3.36e-05	0.00117	CbGpPWpGaD
Saquinavir—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.34e-05	0.00117	CbGpPWpGaD
Saquinavir—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.33e-05	0.00116	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	3.33e-05	0.00116	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.31e-05	0.00115	CbGpPWpGaD
Saquinavir—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.3e-05	0.00115	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.26e-05	0.00114	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	3.24e-05	0.00113	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	3.21e-05	0.00112	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.17e-05	0.0011	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.16e-05	0.0011	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.15e-05	0.0011	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	3.15e-05	0.0011	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	3.15e-05	0.0011	CbGpPWpGaD
Saquinavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.14e-05	0.0011	CbGpPWpGaD
Saquinavir—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	3.13e-05	0.00109	CbGpPWpGaD
Saquinavir—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	3.13e-05	0.00109	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.09e-05	0.00108	CbGpPWpGaD
Saquinavir—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	3.08e-05	0.00107	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	3.07e-05	0.00107	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.03e-05	0.00105	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	3e-05	0.00105	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.95e-05	0.00103	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.94e-05	0.00102	CbGpPWpGaD
Saquinavir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	2.93e-05	0.00102	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.92e-05	0.00102	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	2.92e-05	0.00102	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	2.91e-05	0.00101	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.88e-05	0.001	CbGpPWpGaD
Saquinavir—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	2.86e-05	0.000998	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.86e-05	0.000997	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.81e-05	0.00098	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.81e-05	0.00098	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.78e-05	0.000969	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.78e-05	0.000967	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.78e-05	0.000967	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	2.77e-05	0.000966	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	2.76e-05	0.00096	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.74e-05	0.000956	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.74e-05	0.000956	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.72e-05	0.000949	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	2.71e-05	0.000945	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.68e-05	0.000933	CbGpPWpGaD
Saquinavir—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.66e-05	0.000928	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.66e-05	0.000927	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.66e-05	0.000926	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	2.63e-05	0.000916	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.62e-05	0.000913	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.59e-05	0.000901	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.59e-05	0.000901	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.57e-05	0.000896	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	2.57e-05	0.000894	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.56e-05	0.000894	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.56e-05	0.000893	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.56e-05	0.000893	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	2.54e-05	0.000886	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.52e-05	0.00088	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.52e-05	0.000877	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.51e-05	0.000874	CbGpPWpGaD
Saquinavir—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	2.5e-05	0.000872	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.47e-05	0.000862	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.43e-05	0.000848	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.43e-05	0.000848	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.43e-05	0.000846	CbGpPWpGaD
Saquinavir—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	2.41e-05	0.000841	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.39e-05	0.000835	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.39e-05	0.000833	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.39e-05	0.000833	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.37e-05	0.000825	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.36e-05	0.000824	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.34e-05	0.000817	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.33e-05	0.000813	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.28e-05	0.000793	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.28e-05	0.000793	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.27e-05	0.000791	CbGpPWpGaD
Saquinavir—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	2.26e-05	0.000789	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2.25e-05	0.000783	CbGpPWpGaD
Saquinavir—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.21e-05	0.000769	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.2e-05	0.000766	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.19e-05	0.000764	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.19e-05	0.000761	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.18e-05	0.000759	CbGpPWpGaD
Saquinavir—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.18e-05	0.000758	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.17e-05	0.000756	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.11e-05	0.000734	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	2.09e-05	0.000728	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	2.09e-05	0.000728	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.08e-05	0.000724	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.07e-05	0.00072	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.06e-05	0.000717	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.05e-05	0.000714	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.03e-05	0.000708	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.99e-05	0.000694	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.98e-05	0.000691	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.95e-05	0.00068	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.94e-05	0.000677	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.87e-05	0.000651	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.85e-05	0.000646	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.84e-05	0.000641	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.79e-05	0.000625	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	1.77e-05	0.000615	CbGpPWpGaD
Saquinavir—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	1.75e-05	0.000612	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.73e-05	0.000601	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	1.72e-05	0.000598	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.71e-05	0.000594	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.69e-05	0.000589	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.69e-05	0.000589	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.66e-05	0.00058	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.59e-05	0.000555	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	1.58e-05	0.000552	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.58e-05	0.000552	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	1.58e-05	0.000552	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.55e-05	0.000539	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.54e-05	0.000537	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.51e-05	0.000526	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.5e-05	0.000524	CbGpPWpGaD
Saquinavir—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	1.5e-05	0.000523	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.5e-05	0.000522	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.48e-05	0.000514	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000505	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.000503	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.44e-05	0.000501	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.43e-05	0.000498	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.42e-05	0.000496	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.42e-05	0.000495	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.42e-05	0.000494	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.4e-05	0.000489	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.39e-05	0.000483	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.36e-05	0.000476	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.35e-05	0.000471	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.34e-05	0.000468	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.31e-05	0.000458	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.31e-05	0.000456	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.31e-05	0.000456	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	1.3e-05	0.000453	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.3e-05	0.000452	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.29e-05	0.000451	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.29e-05	0.000449	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.22e-05	0.000426	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.22e-05	0.000426	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.19e-05	0.000416	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.19e-05	0.000413	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.18e-05	0.000412	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.18e-05	0.000411	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.17e-05	0.000407	CbGpPWpGaD
Saquinavir—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	1.16e-05	0.000405	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.14e-05	0.000397	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-05	0.000395	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000392	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.12e-05	0.000391	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.08e-05	0.000377	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.08e-05	0.000375	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.07e-05	0.000374	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.07e-05	0.000371	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.06e-05	0.000371	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.04e-05	0.000364	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.000363	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.03e-05	0.000359	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.02e-05	0.000354	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.01e-05	0.000352	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	9.73e-06	0.000339	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.71e-06	0.000338	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.6e-06	0.000335	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	9.26e-06	0.000323	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	9.25e-06	0.000322	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	8.56e-06	0.000298	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	8.55e-06	0.000298	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	8.49e-06	0.000296	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.18e-06	0.000285	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.13e-06	0.000283	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.11e-06	0.000283	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	7.96e-06	0.000277	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.9e-06	0.000275	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.46e-06	0.00026	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.41e-06	0.000258	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.3e-06	0.000254	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.03e-06	0.000245	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.03e-06	0.000245	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.02e-06	0.000245	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.99e-06	0.000244	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.67e-06	0.000232	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.65e-06	0.000232	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.46e-06	0.000225	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.42e-06	0.000224	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.34e-06	0.000221	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.27e-06	0.000219	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	6.13e-06	0.000214	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.12e-06	0.000213	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.87e-06	0.000204	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.82e-06	0.000203	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.77e-06	0.000201	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.76e-06	0.000201	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.72e-06	0.000199	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.63e-06	0.000196	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.41e-06	0.000189	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	5.31e-06	0.000185	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	5.31e-06	0.000185	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.3e-06	0.000185	CbGpPWpGaD
Saquinavir—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	5.28e-06	0.000184	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.26e-06	0.000183	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	4.74e-06	0.000165	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.63e-06	0.000161	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.36e-06	0.000152	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.32e-06	0.000151	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.2e-06	0.000146	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.77e-06	0.000131	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.64e-06	0.000127	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.62e-06	0.000126	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.47e-06	0.000121	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.25e-06	0.000113	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.17e-06	0.000111	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.99e-06	0.000104	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.96e-06	0.000103	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.85e-06	9.94e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.95e-06	6.81e-05	CbGpPWpGaD
